OMI heads north again
Thursday, 31 July, 2008
Occupational and Medical Innovations [ASX: OMI] has found a Canadian distribution partner for its auto-retractable safety syringes.
OMI has granted Domrex Pharma exclusive rights to distribute the syringes in Canada, but OMI's pre-existing deal granting Cardinal Health distribution rights in Canada will still be honoured.
The deal will last three years, and will be extended if minimum sales targets are met.
The safety syringes have yet to be approved for sale in Canada, but OMI expects to obtain regulatory approvals in late August or early September.
OMI announced yesterday that the Federal Court of Australia had found that its syringe device did not infringe the patent of US competitor Retractable Technologies (RTI).
RTI is also suing Becton Dickinson (BD) in the US for patent infringement.
Overuse of inhalers can increase heart attack risk
Overuse of reliever inhalers is associated with higher risks of developing and dying from...
Unhealthy Western diet could accelerate cognitive decline
An unhealthy Western-style diet is associated with a faster cognitive decline in people with a...
Cancer drug enters clinical trials based on a false mechanism
A cancer drug currently being tested in patients appears to have entered clinical trials based on...
